Equity Analysis

Key Financial Ratios
    Lyka Labs Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    500259
    INE933A01014
    36.6360325
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    LYKALABS
    134.68
    533.57
    EPS(TTM)
    Face Value()
    Div & Yield %:
    1.11
    10
    0
     
   ParticularsMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debt-Equity Ratio0.731.645.7712.151.91
Long Term Debt-Equity Ratio0.601.024.2011.231.71
Current Ratio1.250.680.620.840.83
Fixed Assets0.690.500.980.410.35
Inventory12.9010.6626.3412.446.99
Debtors4.964.6411.967.552.25
Interest Cover Ratio0.810.484.020.28-0.44
PBIDTM (%)15.1823.6458.1424.41-1.52
PBITM (%)3.636.8648.7711.48-20.59
PBDTM (%)10.679.2846.02-16.62-48.18
CPM (%)9.429.0533.64-10.30-49.07
APATM (%)-2.13-7.7324.28-23.23-68.14
ROCE (%)0.000.0035.980.000.00
RONW (%)0.000.0058.270.000.00